On ECHEMI
Home > Drugs > Upper gastrointestinal bleeding
Upper gastrointestinal bleeding
Upper gastrointestinal bleeding refers to bleeding caused by lesions of the esophagus, stomach, duodenum, upper jejunum (about 50 cm below the suspensory ligament of the duodenum), pancreatic duct and bile duct. Its clinical manifestations are mainly hematemesis and black stools, and it is a common surgical emergency.
  • Site of disease:

    Gastrointestinal
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Vomiting blood Black stool Pale face Cold sweat Palpitations
  • Concurrent disease:

Related Drugs
Pantoprazole Sodium for Injection
Indication: It is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, complex ulcers, etc.
Manufacturer:

Hainan Weikang Pharmaceutical(Qianshan) Co., Ltd.

Pantoprazole Sodium for Injection
Indication: It is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, complex ulcers, etc.
Manufacturer:

Hubei Wushi Pharmaceutical Co., Ltd.

Pantoprazole Sodium for Injection
Indication: It is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, complex ulcers, etc.
Manufacturer:

Ma'anshan Fengyuan Pharmaceutical Co., Ltd.

Pantoprazole Sodium for Injection
Indication: It is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, complex ulcers, etc.
Manufacturer:

Fuan Pharmaceutical Group Hubei Renmin Pharmaceutical Co., Ltd.

Pantoprazole Sodium for Injection
Indication: It is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, complex ulcers, etc.
Manufacturer:

Hubei Hepu Pharmaceutical Co., Ltd.

Pantoprazole Sodium for Injection
Indication: It is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, complex ulcers, etc.
Octreotide acetate
Indication: This product is only suitable for acromegaly and some digestive tract carcinoids and neuroendocrine tumors that require long-term administration. It is not suitable for short-term treatment of acute pancreatitis, upper gastrointestinal bleeding, etc.
Manufacturer:

Hainan Zhonghe Pharmaceutical Co., Ltd.

Aminocaproic acid tablets
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. (1) Bleeding caused by trauma or surgery of organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, and thyroid glands, and bleeding caused by excessive amounts of tissue plasminogen activator (t-PA), streptokinase, or urokinase. (2) It can be used as an adjuvant treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophiliacs. (3) It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura, and leukemia. It has a significant effect on general chronic oozing; it has a poor effect on bleeding caused by abnormal coagulation function; and it has no hemostatic effect on severe bleeding, massive bleeding from wounds, and bleeding from cancer.
Manufacturer:

Wuxi Jiyu Shanhe Pharmaceutical Co., Ltd.

Aminocaproic acid injection
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. ⑴ Bleeding caused by trauma or surgery in organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, thyroid glands, and bleeding caused by excessive tissue plasminogen activator (t-PA), streptokinase or urokinase. ⑵ Late stage of disseminated intravascular coagulation (DIC) to prevent secondary hyperfibrinolysis. ⑶ It can be used as an auxiliary treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophilia patients. ⑷ It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura and leukemia. It has a significant effect on general chronic oozing; it has poor efficacy on bleeding caused by abnormal coagulation function; it is effective for severe bleeding, heavy bleeding from wounds and bleeding from cancer, etc.
Aminocaproic acid injection
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. ⑴ Bleeding caused by trauma or surgery in organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, thyroid glands, and bleeding caused by excessive tissue plasminogen activator (t-PA), streptokinase or urokinase. ⑵ Late stage of disseminated intravascular coagulation (DIC) to prevent secondary hyperfibrinolysis. ⑶ It can be used as an auxiliary treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophilia patients. ⑷ It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura and leukemia. It has a significant effect on general chronic oozing; it has poor efficacy on bleeding caused by abnormal coagulation function; it is effective for severe bleeding, heavy bleeding from wounds and bleeding from cancer, etc.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.